Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Brain Research

• Publication date

  2015-03-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.brainres.2014.11.031PMID 25463029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localization of CGRP Receptor Components, CGRP and Receptor Binding Sites in Rhesus Brainstem: A Detailed Study Using In Situ Hybridization and Autoradiography

  2015influential reference
• PACAP and its receptors in migraine pathophysiology: Commentary on Walker et al., Br J Pharmacol 171: 1521–1533

  2015cited by this paper
• mRNA distribution of CGRP and its receptor components in the trigeminovascular system and other pain related structures in rat brain, and effect of intracerebroventricular administration of CGRP on Fos expression in the TNC.

  2014cited by this paper
• Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists.

  2014cited by this paper
• PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy

  2013cited by this paper
• Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study.

  2013cited by this paper
• Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment

  2013cited by this paper
• Calcitonin Gene‐Related Peptide (CGRP) and Migraine Current Understanding and State of Development

  2013cited by this paper
• Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine

  2013cited by this paper
• Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.

  2013influential reference
• In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232

  2013cited by this paper
• CGRP and migraine: could PACAP play a role too?

  2013cited by this paper
• Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients

  2013cited by this paper
• CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?

  2013cited by this paper
• Migraine: a brain state.

  2013cited by this paper
• Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system

  2013cited by this paper
• Localization of CGRP Receptor Components, CGRP, and Receptor Binding Sites in Human and Rhesus Cerebellar Cortex

  2013cited by this paper
• Antibody drugs set to revive flagging migraine target

  2013cited by this paper
• Pathophysiology of migraine

  2012cited by this paper
• Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine

  2012cited by this paper
• Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers

  2012cited by this paper
• CGRP receptor antagonists: an expanding drug class for acute migraine?

  2012cited by this paper
• Increase in CGRP- and nNOS-immunoreactive neurons in the rat trigeminal ganglion after infusion of an NO donor

  2011cited by this paper
• Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy.

  2011cited by this paper
• CGRP receptor antagonists: toward a novel migraine therapy.

  2011cited by this paper
• CGRP receptor antagonists: toward a novel migraine therapy.

  2011cited by this paper
• Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation

  2011cited by this paper
• Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: findings from array analysis.

  2010cited by this paper
• Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist

  2010cited by this paper
• Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries

  2010cited by this paper
• Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine

  2010cited by this paper
• CGRP and its receptors provide new insights into migraine pathophysiology

  2010cited by this paper
• New drugs in migraine treatment and prophylaxis: telcagepant and topiramate.

  2010cited by this paper
• Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura

  2010cited by this paper
• Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries

  2010cited by this paper
• Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.

  2010influential reference
• Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist.

  2010cited by this paper
• Possible sites of action of the new calcitonin gene-related peptide receptor antagonists

  2010cited by this paper
• Characterization of the CGRP receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries

  2010cited by this paper
• Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine?

  2010cited by this paper
• PACAP38 induces migraine-like attacks in patients with migraine without aura.

  2009cited by this paper
• Brainstem and Thalamic Projections from a Craniovascular Sensory Nervous Centre in the Rostral Cervical Spinal Dorsal Horn of Rats

  2009cited by this paper
• Therapeutic potential of novel glutamate receptor antagonists in migraine

  2009cited by this paper
• Migraine pathogenesis and state of pharmacological treatment options

  2009cited by this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

  2009cited by this paper
• Calcitonin receptor‐like receptor (CLR), receptor activity‐modifying protein 1 (RAMP1), and calcitonin gene‐related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution

  2008cited by this paper
• Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling

  2008cited by this paper
• Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.

  2008cited by this paper
• Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells.

  2008cited by this paper
• The Blood-Brain Barrier in Migraine Treatment

  2008cited by this paper
• Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

  2008cited by this paper
• Sensitization of Calcitonin Gene-Related Peptide Receptors by Receptor Activity-Modifying Protein-1 in the Trigeminal Ganglion

  2007cited by this paper
• Recent advances in understanding migraine mechanisms, molecules and therapeutics.

  2007cited by this paper
• Inhibitory effect of BIBN4096BS, CGRP8–37, a CGRP antibody and an RNA‐Spiegelmer on CGRP induced vasodilatation in the perfused and non‐perfused rat middle cerebral artery

  2007cited by this paper
• The role of glutamate and its receptors in migraine.

  2007cited by this paper
• Salivary Levels of CGRP and VIP in Rhinosinusitis and Migraine Patients

  2006cited by this paper
• PATHOPHYSIOLOGY OF MIGRAINE

  2006cited by this paper
• Functional Imaging of the Trigeminal System: Applications to Migraine Pathophysiology

  2006cited by this paper
• Correlation Between Lipophilicity and Triptan Outcomes

  2005cited by this paper
• Most peptide‐containing sensory neurons lack proteins for exocytotic release and vesicular transport of glutamate

  2005cited by this paper
• Calcitonin gene–related peptide does not excite or sensitize meningeal nociceptors: Implications for the pathophysiology of migraine

  2005cited by this paper
• Cortical spreading depression activates and upregulates MMP-9.

  2004cited by this paper
• Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

  2004cited by this paper
• Neuropeptide Expression in the Human Trigeminal Nucleus Caudalis and in the Cervical Spinal Cord C1 and C2

  2002cited by this paper
• Neuropeptide Localization in the ‘Migraine Generator’ Region of the Human Brainstem

  2001cited by this paper
• An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system

  2001cited by this paper
• Origin and co‐localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat

  2001cited by this paper
• 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase.

  2001cited by this paper
• Messenger molecules and receptor mRNA in the human trigeminal ganglion.

  1999cited by this paper
• Release of Histamine from Dural Mast Cells by Substance P and Calcitonin Gene-Related Peptide

  1997cited by this paper
• Vascular permeability in the peripheral autonomic and somatic nervous systems: Controversial aspects and comparisons with the blood‐brain barrier

  1996cited by this paper
• Cerebrospinal Fluid Analyses in Migraine Patients and Controls

  1995cited by this paper
• Inhibition by sumatriptan of central trigeminal neurones only after blood‐brain barrier disruption

  1993cited by this paper
• Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: Immunocytochemical and immunochemical evidence

  1993cited by this paper
• The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats

  1993cited by this paper
• Sub-populations of smaller diameter trigeminal primary afferent neurons defined by expression of calcitonin gene-related peptide and the cell surface oligosaccharide recognized by monoclonal antibody LA4.

  1991cited by this paper
• Glutamate-immunoreactivity in the trigeminal and dorsal root ganglia, and intraspinal neurons and fibres in the dorsal horn of the rat

  1991cited by this paper
• Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with fluoro-gold.

  1991cited by this paper
• Origins and distribution of cerebrovascular nerve fibers showing calcitonin gene‐related peptide‐like immunoreactivity in the major cerebral artery of the dog

  1990cited by this paper
• Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

  1990cited by this paper
• Extracerebral manifestations in migraine. A peptidergic involvement?

  1990cited by this paper
• Satellite cells as blood-ganglion cell barrier in autonomic ganglia.

  1989cited by this paper
• Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

  1988cited by this paper
• Cerebral arterial innervation by nerve fibers containing calcitonin gene‐related peptide (CGRP): I. Distribution and origin of CGRP perivascular innervation in rat

  1988cited by this paper
• Immunoelectron microscopic study of substance P-containing fibers in feline cerebral arteries.

  1986cited by this paper
• Vascular permeability to fluorescent protein tracer in trigeminal nerve and gasserian ganglion

  1973cited by this paper

• Understanding RAMP1’s role in hormonal migraine may improve CGRP-targeted therapies

  2026cites this paper
• Meningeal neuropeptide and neuroimmune interactions in the context of migraine.

  2026cites this paper
• Hypothalamic and sex-related hormones in migraine

  2026cites this paper
• Non-neuronal targets for migraine therapy.

  2026cites this paper
• Neurologic Symptoms and Cerebrovascular Events During Atogepant Therapy: A Case Series with Contextual Comparison with a Non-Gepant–Treated Migraine Cohort

  2026cites this paper
• Gepants: targeting the CGRP pathway for migraine relief

  2025cites this paper
• Treating Menière's disease with rimegepant.

  2025cites this paper
• Gasotransmitters (NO, H2S, CO) as Contributors to the Nociceptive Process in the Trigeminovascular System

  2025cites this paper
• The link between spreading depolarization and innate immunity in the central nervous system

  2025cites this paper
• PACAP versus CGRP in migraine: From mouse models to clinical translation

  2025cites this paper
• Unmasking the relationship between CGRP and glutamate: from peripheral excitation to central sensitization in migraine

  2025cites this paper
• CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke

  2025cites this paper
• Associations Between Fatty Acid Levels in Human Blood and Trigeminovascular Tissues

  2025cites this paper
• Ex vivo stimulation of the trigeminal nucleus caudalis induces peripheral CGRP release in the trigeminal ganglion and reveals a distinct dopamine–endocannabinoid mechanism relevant to migraine

  2025cites this paper
• A Murine Model of High Dietary Histamine Intake: Impact on Histamine Contents and Release in Neural and Extraneural Tissues

  2025cites this paper
• Comparison of gepant effects at therapeutic plasma concentrations: connecting pharmacodynamics and pharmacokinetics

  2024cites this paper
• A real-world pharmacovigilance study of FDA adverse event reporting system events for atogepant

  2024cites this paper
• Migraine and the microbiota. Can probiotics be beneficial in its prevention? - a narrative review

  2024cites this paper
• A Review of Calcitonin Gene-Related Peptide and Its Implications for Vestibular Disorders

  2024cites this paper
• Novel Calcitonin Gene-Related Peptide (CGRP) Interfering Migraine Therapies and Stroke—A Review

  2024cites this paper
• A new path to migraine

  2024cites this paper
• Regulation of headache response and transcriptomic network by the trigeminal ganglion clock

  2024cites this paper
• Migraine Duration as a Potential Amplifier of Obesity

  2024cites this paper
• Understanding the Biological Relationship between Migraine and Depression

  2024cites this paper
• The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative review

  2024cites this paper
• Metabolic Dysfunction in Idiopathic Intracranial Hypertension: Current Theories and Updates

  2024cites this paper
• Pituitary cyclase‐activating polypeptide targeted treatments for the treatment of primary headache disorders

  2024cites this paper
• CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention.

  2024cites this paper
• Novel insight into atogepant mechanisms of action in migraine prevention

  2024cites this paper
• Is calcitonin gene-related peptide (CGRP) the missing link in food histamine-induced migraine? A review of functional gut-to-trigeminovascular system connections.

  2024cites this paper
• Implications of high homocysteine levels in migraine pain: An experimental study of the excitability of peripheral meningeal afferents in rats with hyperhomocysteinemia

  2024cites this paper
• Progesterone distribution in the trigeminal system and its role to modulate sensory neurotransmission: influence of sex

  2023cites this paper
• Calcitonin Gene-Related Peptide and Trigeminal Neuralgia

  2023cites this paper
• Development of a New Enzyme-Linked Immunosorbent Assay (ELISA) for Measuring the Content of PACAP in Mammalian Tissue and Plasma

  2023cites this paper
• Targeting CGRP pathways and aura: A peripheral site with a central effect

  2023cites this paper
• Calcitonin/PAC1 receptor splice variants: a blind spot in migraine research.

  2023cites this paper
• Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System

  2023cites this paper
• A systematic literature review on the role of glial cells in the pathomechanisms of migraine

  2023cites this paper
• High plasma calcitonin gene-related peptide and serum pituitary adenylate cyclase-activating polypeptide levels in patients with neuropathic pain.

  2023cites this paper
• Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues

  2023cites this paper
• Mode and site of action of therapies targeting CGRP signaling

  2023cites this paper
• Temporal alterations of pituitary adenylate cyclase activating polypeptide and its receptors in a rat model induced by recurrent chemical stimulations: Relevant to chronic migraine

  2023cites this paper
• Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review

  2023cites this paper
• Shared and independent roles of CGRP and PACAP in migraine pathophysiology

  2023cites this paper
• Calcitonin Gene-Related Peptide mRNA Synthesis in Trigeminal Ganglion Neurons after Cortical Spreading Depolarization

  2023cites this paper
• Molecular Mechanisms of Migraine: Nitric Oxide Synthase and Neuropeptides

  2023cites this paper
• Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases

  2023cites this paper
• Adverse event profile of CGRP monoclonal antibodies: findings from the FDA adverse event reporting database

  2023cites this paper
• Inflammatory Orofacial Pain Activates Peptidergic Neurons and Upregulates the Oxytocin Receptor Expression in Trigeminal Ganglion

  2023influential citation
• Neurogenic inflammation as a novel treatment target for chronic pain syndromes.

  2022cites this paper
• Calcitonin gene‐related peptide (CGRP) is a key molecule released in acute migraine attacks—Successful translation of basic science to clinical practice

  2022cites this paper
• The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?

  2022cites this paper
• Testing the Role of Glutamate NMDA Receptors in Peripheral Trigeminal Nociception Implicated in Migraine Pain

  2022cites this paper
• Decreased PPARgamma in the trigeminal spinal subnucleus caudalis due to neonatal injury contributes to incision-induced mechanical allodynia in female rats

  2022cites this paper
• Localization of the neuropeptides pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and their receptors in the basal brain blood vessels and trigeminal ganglion of the mouse CNS; an immunohistochemical study

  2022cites this paper
• Calcitonin gene-related peptide and neurologic injury: An emerging target for headache management.

  2022cites this paper
• CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons

  2022cites this paper
• α6-Containing GABAA Receptors: Functional Roles and Therapeutic Potentials

  2022cites this paper
• Peripheral mechanisms of chronic pain

  2022cites this paper
• Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale

  2022cites this paper
• Dual action of the cannabinoid receptor 1 ligand arachidonyl-2′-chloroethylamide on calcitonin gene-related peptide release

  2022influential citation
• The impact of obesity; key features of raised intracranial pressure and clinical sequalae in rodents

  2022cites this paper
• CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond.

  2022cites this paper
• Role of PACAP in migraine: An alternative to CGRP?

  2022cites this paper
• Rimegepant for the treatment of migraine.

  2022cites this paper
• The role of cytokines in migraine: A systematic review

  2022cites this paper
• A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene‐related peptide and beyond

  2022cites this paper
• Exploring the Tryptophan Metabolic Pathways in Migraine-Related Mechanisms

  2022cites this paper
• The impact of obesity-related raised intracranial pressure in rodents

  2022cites this paper
• Gepants — a long way to cure: a narrative review

  2022cites this paper
• Pituitary Adenylate Cyclase Activating Peptide and Post-traumatic Stress Disorder: From Bench to Bedside

  2022cites this paper
• Ex vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents.

  2022cites this paper
• CGRP-dependent sensitization of PKC-δ positive neurons in central amygdala mediates chronic migraine

  2022cites this paper
• New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database

  2021cites this paper
• Functional Chemoanatomy of PACAP in Neuroendocrine and Neuronal Circuits

  2021cites this paper
• Rational Use of Lasmiditan for Acute Migraine Treatment in Adults: A Narrative Review.

  2021cites this paper
• Delta opioid receptor regulation of CGRP dynamics in the trigeminal complex.

  2021cites this paper
• Migraine

  2021cites this paper
• Effects of ligustrazine on the expression of neurotransmitters in the trigeminal ganglion of a rat migraine model

  2021cites this paper
• Hormonal influences in migraine — interactions of oestrogen, oxytocin and CGRP

  2021cites this paper
• Identifying New Antimigraine Targets: Lessons from Molecular Biology.

  2021cites this paper
• Was it something I ate? Understanding the bidirectional interaction of migraine and appetite neural circuits.

  2021cites this paper
• Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension

  2021cites this paper
• A peptide encoded within a 5' untranslated region promotes pain sensitization in mice.

  2021cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide: A Potent Therapeutic Agent in Oxidative Stress

  2021cites this paper
• Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects

  2021cites this paper
• Rimegepant: acute treatment for migraine headaches.

  2021cites this paper
• Biological and small molecule strategies in migraine therapy with relation to the calcitonin gene‐related peptide family of peptides

  2021cites this paper
• CGRP and CGRP-receptor as targets of migraine therapy: Brain Prize-2021.

  2021cites this paper
• Title: Calcitonin Gene Related Peptide in migraine: current therapeutics, future implications and potential off-target effects

  2021cites this paper
• Updated review on the link between cortical spreading depression and headache disorders

  2021cites this paper
• Dysregulation of the peripheral glutamatergic system: A key player in migraine pathogenesis?

  2021cites this paper
• Potential Side Effects and Pregnancy

  2021cites this paper
• Pharmacology; Where Do the mAbs Act, Gepants Versus mAbs

  2021cites this paper
• Targets for migraine treatment: beyond calcitonin gene-related peptide

  2021cites this paper
• Interoception and the origin of feelings: A new synthesis

  2021cites this paper
• Pathognomonic Hypersensitivity of the Oral Mucosa and Tongue Induced by Diabetes Mellitus Accompanied by Saliva Reduction in Rats.

  2021cites this paper
• Evidence that blood–CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen

  2021cites this paper
• Review of Literatures: Physiology of Orofacial Pain in Dentistry

  2021cites this paper
• Migraine: Calcium Channels and Glia

  2021cites this paper